KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Colgate Palmolive (CL) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Colgate Palmolive's Free Cash Flow rose 706.68% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year increase of 126.47%. This contributed to the annual value of $3.5 billion for FY2024, which is 1664.47% up from last year.
  • As of Q3 2025, Colgate Palmolive's Free Cash Flow stood at $1.1 billion, which was up 706.68% from $776.0 million recorded in Q2 2025.
  • In the past 5 years, Colgate Palmolive's Free Cash Flow registered a high of $1.1 billion during Q3 2025, and its lowest value of $264.0 million during Q1 2022.
  • For the 5-year period, Colgate Palmolive's Free Cash Flow averaged around $713.8 million, with its median value being $776.0 million (2025).
  • Its Free Cash Flow has fluctuated over the past 5 years, first crashed by 5049.29% in 2022, then surged by 11666.67% in 2023.
  • Colgate Palmolive's Free Cash Flow (Quarter) stood at $913.0 million in 2021, then plummeted by 50.49% to $452.0 million in 2022, then surged by 107.74% to $939.0 million in 2023, then grew by 15.55% to $1.1 billion in 2024, then increased by 1.94% to $1.1 billion in 2025.
  • Its Free Cash Flow stands at $1.1 billion for Q3 2025, versus $776.0 million for Q2 2025 and $476.0 million for Q1 2025.